| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. | Chief Operating Officer | Common Stock | 374,674 | $4,488,595 | $11.98 | 14 Feb 2024 | Direct |
| Neumora Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 170,000 | 14 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. | 14 Feb 2024 | 2 | $0 | 4 | Chief Operating Officer | 16 Feb 2024, 16:19 |
| NMRA | Neumora Therapeutics, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Chief Operating Officer | 14 Sep 2023, 19:04 |